EXANE DERIVATIVES - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$87,268,000
+6926.4%
2,279
+7496.7%
0.05%
Q1 2022$1,242,000
+9.6%
300.0%0.00%
Q4 2021$1,133,000
+14.6%
300.0%0.00%
Q3 2021$989,000
-99.6%
30
-99.3%
0.00%
-100.0%
Q2 2021$282,022,000
+12.0%
4,4470.0%0.06%
-11.1%
Q1 2021$251,778,000
-27.4%
4,447
+4.4%
0.07%
-29.4%
Q4 2020$346,883,000
+291.7%
4,258
+242.6%
0.10%
+292.3%
Q3 2020$88,559,000
-17.2%
1,243
-4.4%
0.03%
-10.3%
Q2 2020$106,957,000
+39.9%
1,3000.0%0.03%
+38.1%
Q1 2020$76,476,0001,3000.02%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders